Bing Xie

GPCR-mediated β-arrestin activation deconvoluted with single-molecule precision

Wesley B. Asher, Daniel S. Terry, G. Glenn Gregorio et al. · Cell · 2022 · 102 citations · Full text

Receptor Tail, Gpcr-mediated β-Arrestin Activation, Cellular Physiology +17

Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor

R. Benjamin Free, Caroline A. Cuoco, Bing Xie et al. · Molecular Pharmacology · 2021 · 34 citations · Full text

A comprehensive evaluation of the potential binding poses of fentanyl and its analogs at the µ-opioid receptor

Bing Xie, Alexander Goldberg, Lei Shi · Computational and Structural Biotechnology Journal · 2022 · 22 citations · Full text

Drug Target, Fentanyl, Pharmacotherapy +21

Chirality of Novel Bitopic Agonists Determines Unique Pharmacology at the Dopamine D3 Receptor

Pramisha Adhikari, Bing Xie, Ana Semeano et al. · Biomolecules · 2021 · 19 citations · Full text

Binding preference at the μ-opioid receptor underlies distinct pharmacology of cyclopropyl versus valeryl analogs of fentanyl

Bing Xie, Valerie P. Le Rouzic, Alexander Goldberg et al. · Neuropharmacology · 2023 · 15 citations · Full text

Molecular Pharmacology, Medicine, Behavioral Pharmacology +8